Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

Solventum (SOLV) Long-Term Debt Repayments (2024 - 2025)

Solventum posted quarterly Long-Term Debt Repayments of $100.0 million for Q4 2025, little changed year-on-year from $100.0 million in Q4 2024, and down 96.39% on a QoQ basis from $2.8 billion in Q3 2025.

Solventum (SOLV) has 2 years of Long-Term Debt Repayments data on file, last reported at $100.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Repayments changed 0.0% year-over-year to $100.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 billion (up 642.5% YoY), and the FY2025 full-year result was $3.1 billion, up 923.33% from the prior year.
  • Long-Term Debt Repayments for Q4 2025 stood at $100.0 million, down from $2.8 billion in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $2.8 billion in Q3 2025 and bottomed at $100.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 2.00 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 904.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 127.93 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 100.00 Mn
Dec 31, 2025 100.00 Mn
Sep 30, 2025 2.77 Bn
Sep 30, 2025 2.77 Bn
Jun 30, 2025 100.00 Mn
Jun 30, 2025 100.00 Mn
Mar 31, 2025 100.00 Mn
Mar 31, 2025 100.00 Mn
Dec 31, 2024 100.00 Mn
Dec 31, 2024 100.00 Mn
Sep 30, 2024 200.00 Mn
Sep 30, 2024 200.00 Mn